Learn biotech investing by following real catalysts.
Upcoming trial readouts and clinical pipelines for 7 biotech companies, taken from ClinicalTrials.gov and linked to plain explanations of what each milestone means.
Next catalysts
All 42-
Dec 2026Beam Therapeutics · N/ASickle Cell Trait · Recruiting · NCT06071377
-
Dec 2026Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia · Active, not recruiting · NCT05885464
-
19 May 2027Multiple Myeloma, Smoldering Multiple Myeloma · Recruiting · NCT05841550
-
6 Jun 2027Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance · Active, not recruiting · NCT05329649
-
9 Jun 2027Beta-Thalassemia, Thalassemia, Hematologic Diseases · Recruiting · NCT05477563
-
Jun 2027Cardiovascular, Metabolic Disease, Dyslipidemias · Recruiting · NCT07491172
-
Jun 2027Pancreatic Ductal Adenocarcinoma, Refractory Non-Small Cell Lung Cancer · Active, not recruiting · NCT06015724
-
Jul 2027Neuromuscular Disease, Neuromuscular Diseases (NMD), Neurodegenerative Disease · Recruiting · NCT06672237
Dates are the estimated primary completion dates reported to ClinicalTrials.gov. Results are often announced weeks or months later, and sponsors move dates. Data fetched 7 October 2026.
Companies
All companies- BEAMBeam Therapeutics8 active studies · next Dec 2026
- CRSPCRISPR Therapeutics11 active studies · next 6 Jun 2027
- CRNO-B.STCereno Scientific AB1 active study · next 2 Feb 2029
- CRNA.OLCircio Holding ASA3 active studies · next 19 May 2027
- NTLAIntellia Therapeutics7 active studies · next Jul 2027
- MRNAModerna1 active study
- VRTXVertex Pharmaceuticals16 active studies · next 9 Jun 2027